{"id":3243,"date":"2012-11-21T07:30:00","date_gmt":"2012-11-21T07:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/ny-salj-och-marknadsdirektor-pa-xvivo-perfusion\/"},"modified":"2012-11-21T07:30:00","modified_gmt":"2012-11-21T07:30:00","slug":"ny-salj-och-marknadsdirektor-pa-xvivo-perfusion","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/ny-salj-och-marknadsdirektor-pa-xvivo-perfusion\/","title":{"rendered":"Ny S\u00e4lj- och Marknadsdirekt\u00f6r p\u00e5 XVIVO Perfusion"},"content":{"rendered":"
Christer de Flon har utsetts till S\u00e4lj och Marknadsdirekt\u00f6r med ansvar f\u00f6r alla marknads- och s\u00e4ljaktiviteter inom Xvivo Perfusion. Han kommer n\u00e4rmast fr\u00e5n Bl\u00e5 Stj\u00e4rnan d\u00e4r han \u00e4r VD.<\/strong><\/div>\n<\/p>\n

Christer de Flon har tidigare yrkeserfarenheter fr\u00e5n ledande befattningar inom H\u00e4ssle, Astra-H\u00e4ssle, AstraZeneca, VD f\u00f6r Carlsson Research AB, vVD Vitrolife AB och senast VD f\u00f6r Bl\u00e5 Stj\u00e4rnans Djursjukhus. Christer tilltr\u00e4der sin befattning senast den 1 Maj 2013.<\/span><\/p>\n<\/p>\n

\u201dMed sin gedigna erfarenhet av f\u00f6rs\u00e4ljning och marknadsf\u00f6ring kommer Christer att bli en utomordentlig tillg\u00e5ng f\u00f6r oss i arbetet med att etablera STEEN Solution\u2122 p\u00e5 marknaden. Vi h\u00e4lsar Christer varmt v\u00e4lkommen till XVIVO Perfusion och uppdraget som S\u00e4lj- och Marknadsdirekt\u00f6r. Jag \u00e4r glad \u00f6ver att f\u00e5 en ytterst kompetent och erfaren medarbetare till v\u00e5rt f\u00f6retag\u201d, s\u00e4ger XVIVO Perfusions VD Magnus Nilsson.<\/span><\/p>\n<\/p>\n

G\u00f6teborg 20 november 2012
XVIVO Perfusion AB (publ)
Magnus Nilsson
Verkst\u00e4llande direkt\u00f6r<\/span><\/p>\n<\/p>\n

\n

F\u00f6r ytterligare information kontakta: <\/span><\/p>\n

Magnus Nilsson, VD, tel: 031-788 21 50, e-post: magnus.nilsson@xvivoperfusion.com<\/a><\/span>
Christoffer Rosenblad, CFO, tel: 073-519 21 59, e-post: christoffer.rosenblad@xvivoperfusion.com<\/a>
F\u00f6r ytterligare information om Xvivo Perfusions verksamhet h\u00e4nvisas till bolagets hemsida, www.xvivoperfusion.com<\/a><\/span><\/p>\n

Xvivo Perfusion\u00a0\u00e4r skyldigt att offentligg\u00f6ra informationen i detta pressmeddelande enligt lagen om v\u00e4rdepappersmarknaden och\/eller lagen om handel med finansiella instrument. Informationen l\u00e4mnades f\u00f6r publicering den\u00a021 november 2012 kl. 08:30.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Christer de Flon har utsetts till S\u00e4lj och Marknadsdirekt\u00f6r med ansvar f\u00f6r alla marknads- och s\u00e4ljaktiviteter inom Xvivo Perfusion. Han…<\/p>\n","protected":false},"template":"","class_list":["post-3243","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-vpml","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-staff"],"acf":[],"yoast_head":"\nNy S\u00e4lj- och Marknadsdirekt\u00f6r p\u00e5 XVIVO Perfusion - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/ny-salj-och-marknadsdirektor-pa-xvivo-perfusion\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ny S\u00e4lj- och Marknadsdirekt\u00f6r p\u00e5 XVIVO Perfusion - XVIVO\" \/>\n<meta property=\"og:description\" content=\"Christer de Flon har utsetts till S\u00e4lj och Marknadsdirekt\u00f6r med ansvar f\u00f6r alla marknads- och s\u00e4ljaktiviteter inom Xvivo Perfusion. Han...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/ny-salj-och-marknadsdirektor-pa-xvivo-perfusion\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/ny-salj-och-marknadsdirektor-pa-xvivo-perfusion\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/ny-salj-och-marknadsdirektor-pa-xvivo-perfusion\\\/\",\"name\":\"Ny S\u00e4lj- och Marknadsdirekt\u00f6r p\u00e5 XVIVO Perfusion - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2012-11-21T07:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/ny-salj-och-marknadsdirektor-pa-xvivo-perfusion\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/ny-salj-och-marknadsdirektor-pa-xvivo-perfusion\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/ny-salj-och-marknadsdirektor-pa-xvivo-perfusion\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ny S\u00e4lj- och Marknadsdirekt\u00f6r p\u00e5 XVIVO Perfusion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ny S\u00e4lj- och Marknadsdirekt\u00f6r p\u00e5 XVIVO Perfusion - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/ny-salj-och-marknadsdirektor-pa-xvivo-perfusion\/","og_locale":"en_US","og_type":"article","og_title":"Ny S\u00e4lj- och Marknadsdirekt\u00f6r p\u00e5 XVIVO Perfusion - XVIVO","og_description":"Christer de Flon har utsetts till S\u00e4lj och Marknadsdirekt\u00f6r med ansvar f\u00f6r alla marknads- och s\u00e4ljaktiviteter inom Xvivo Perfusion. Han...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/ny-salj-och-marknadsdirektor-pa-xvivo-perfusion\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/ny-salj-och-marknadsdirektor-pa-xvivo-perfusion\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/ny-salj-och-marknadsdirektor-pa-xvivo-perfusion\/","name":"Ny S\u00e4lj- och Marknadsdirekt\u00f6r p\u00e5 XVIVO Perfusion - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2012-11-21T07:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/ny-salj-och-marknadsdirektor-pa-xvivo-perfusion\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/ny-salj-och-marknadsdirektor-pa-xvivo-perfusion\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/ny-salj-och-marknadsdirektor-pa-xvivo-perfusion\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"Ny S\u00e4lj- och Marknadsdirekt\u00f6r p\u00e5 XVIVO Perfusion"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/3243","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=3243"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}